These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15899507)

  • 21. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
    Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
    J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of Herba Epimedii Flavone on expression of OPG and RANKL in rat osteoblasts].
    Liu Y; Zang H; Zhang H; Chen J
    Zhong Yao Cai; 2005 Dec; 28(12):1076-8. PubMed ID: 16568663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.
    Ueland T; Yndestad A; Øie E; Florholmen G; Halvorsen B; Frøland SS; Simonsen S; Christensen G; Gullestad L; Aukrust P
    Circulation; 2005 May; 111(19):2461-8. PubMed ID: 15883214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse.
    Mori H; Kitazawa R; Mizuki S; Nose M; Maeda S; Kitazawa S
    Histochem Cell Biol; 2002 Mar; 117(3):283-92. PubMed ID: 11914926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
    Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice.
    Sakakura Y; Tsuruga E; Irie K; Hosokawa Y; Nakamura H; Yajima T
    J Anat; 2005 Oct; 207(4):325-37. PubMed ID: 16191162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.
    Bock O; Loch G; Schade U; Büsche G; Wasielewski R; Wiese B; Kreipe H
    Br J Haematol; 2005 Jul; 130(1):76-82. PubMed ID: 15982347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone.
    Roux S; Amazit L; Meduri G; Guiochon-Mantel A; Milgrom E; Mariette X
    Am J Clin Pathol; 2002 Feb; 117(2):210-6. PubMed ID: 11863217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
    Makrygiannakis D; af Klint E; Catrina SB; Botusan IR; Klareskog E; Klareskog L; Ulfgren AK; Catrina AI
    Arthritis Rheum; 2006 May; 54(5):1463-72. PubMed ID: 16646024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronology and regulation of gene expression of RANKL in the rat dental follicle.
    Liu D; Yao S; Pan F; Wise GE
    Eur J Oral Sci; 2005 Oct; 113(5):404-9. PubMed ID: 16202028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
    Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
    J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2.
    Tsuji K; Uno K; Zhang GX; Tamura M
    J Bone Miner Metab; 2004; 22(2):94-103. PubMed ID: 14999519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer mediates osteoclastogenesis through two different pathways.
    Inoue H; Nishimura K; Oka D; Nakai Y; Shiba M; Tokizane T; Arai Y; Nakayama M; Shimizu K; Takaha N; Nonomura N; Okuyama A
    Cancer Lett; 2005 Jun; 223(1):121-8. PubMed ID: 15890244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle.
    Liu D; Yao S; Wise GE
    Eur J Oral Sci; 2006 Feb; 114(1):42-9. PubMed ID: 16460340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF; Lie A; Ransjö M
    J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls.
    Vanderborght A; Linsen L; Thewissen M; Geusens P; Raus J; Stinissen P
    J Rheumatol; 2004 Aug; 31(8):1483-90. PubMed ID: 15290725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells.
    Maddi A; Hai H; Ong ST; Sharp L; Harris M; Meghji S
    Bone; 2006 Aug; 39(2):283-8. PubMed ID: 16567138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.